NYSEMKT: SER
Serina Therapeutics Inc Stock Ownership - Who owns Serina Therapeutics?

Insider buying vs selling

Have Serina Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Juvenescence Ltd10% Owner2025-01-31500,000$10.00
$5.00MBuy
Gregory BaileyDirector2024-12-173,866$4.59
$17.74kBuy
Juvenescence Ltd10% Owner2024-11-27500,000$10.00
$5.00MBuy
Gregory BaileyDirector2024-09-201,137$6.03
$6.85kBuy
Gregory BaileyDirector2024-09-1911,679$6.11
$71.38kBuy
Gregory BaileyDirector2024-09-182,709$6.23
$16.87kBuy
Steven MintzDirector2024-09-126,000$6.47
$38.81kBuy
Gregory BaileyDirector2024-08-201,776$8.25
$14.65kBuy
Gregory BaileyDirector2024-08-196,400$7.93
$50.76kBuy
Gregory BaileyDirector2024-08-166,400$7.31
$46.78kBuy

1 of 4

SER insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SER insiders and whales buy or sell their stock.

SER Shareholders

What type of owners hold Serina Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Juvenescence Ltd225.55%22,481,876$129.16MInsider
Juvenescence Us Corp165.01%16,447,500$94.49MInsider
Steven A. Ledger3.25%323,657$1.86MInsider
John F. Mauldin1.25%125,000$718.13kInsider
Broadwood Capital Inc0.85%85,219$489.58kInstitution
Waverly Advisors LLC0.68%67,492$387.74kInstitution
Gregory Bailey0.67%67,243$386.31kInsider
Vanguard Group Inc0.62%62,073$356.61kInstitution
Tacey Viegas0.59%58,610$336.71kInsider
Judith Segall0.53%52,624$302.32kInsider

1 of 3

SER vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SER0.80%99.20%Net Buying
SKYE3.44%96.56%Net Selling
MGX28.70%33.25%Net SellingNet Selling
APLT81.28%8.04%Net SellingNet Selling
IKNA65.71%18.22%

Serina Therapeutics Stock Ownership FAQ

Who owns Serina Therapeutics?

Serina Therapeutics (NYSEMKT: SER) is owned by 3.20% institutional shareholders, 398.02% Serina Therapeutics insiders, and 0.00% retail investors. Juvenescence Ltd is the largest individual Serina Therapeutics shareholder, owning 22.48M shares representing 225.55% of the company. Juvenescence Ltd's Serina Therapeutics shares are currently valued at $126.57M.

If you're new to stock investing, here's how to buy Serina Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.